PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit

Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will present a company overview on October 1, 2020, at the Jefferies Virtual Gene Therapy/Editing Summit at 9:00 a.m. ET. The presentation will be live-streamed on their website and available for 30 days afterward. PTC Therapeutics focuses on developing medicines for rare disorders, aiming to provide access to innovative treatments for patients with unmet needs. For optimal viewing, it's recommended to connect a few minutes before the start of the webcast.

News Market Reaction – PTCT

+2.14%

+2.14% Session move

In the trading session that priced this news, PTCT gained 2.14%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH PLAINFIELD, N.J., Sept. 24, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 1^st at 9:00 a.m. ET.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:
Media:	Investors:
Jane Baj	Lisa Hayes
+1 (908) 912-9167	+1 (908) 868-8926
jbaj@ptcbio.com	lhayes@ptcbio.com

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-jefferies-virtual-gene-therapyediting-summit-301137035.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics presenting at the Jefferies Virtual Gene Therapy/Editing Summit?

PTC Therapeutics will present on October 1, 2020, at 9:00 a.m. ET.

Where can I watch the PTC Therapeutics presentation from the Jefferies Summit?

The presentation can be watched live on the PTC Therapeutics website in the investor relations section.

How long will the PTC Therapeutics presentation be available online?

The presentation will be archived for 30 days following the event.

What is the focus of PTC Therapeutics as a biopharmaceutical company?

PTC Therapeutics is focused on developing clinically differentiated medicines for rare disorders.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.